Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
nitric oxide synthase inhibitor |
| gptkbp:administeredBy |
animal studies
|
| gptkbp:CASNumber |
51298-62-5
|
| gptkbp:category |
arginine derivative
pharmacological inhibitor |
| gptkbp:chemicalFormula |
C7H15N5O4
|
| gptkbp:effect |
induces hypertension in animal models
reduces nitric oxide production |
| https://www.w3.org/2000/01/rdf-schema#label |
L-NAME
|
| gptkbp:inhibitedBy |
nitric oxide synthase
|
| gptkbp:IUPACName |
Nω-Nitro-L-arginine methyl ester
|
| gptkbp:molecularWeight |
233.22 g/mol
|
| gptkbp:relatedTo |
gptkb:L-arginine
|
| gptkbp:routeOfAdministration |
oral
intraperitoneal injection |
| gptkbp:solubility |
water soluble
|
| gptkbp:synonym |
L-NG-Nitroarginine methyl ester
N(G)-Nitro-L-arginine methyl ester |
| gptkbp:used_in |
biomedical research
|
| gptkbp:usedFor |
tool compound
|
| gptkbp:bfsParent |
gptkb:Nitric_oxide_synthase
|
| gptkbp:bfsLayer |
7
|